Suzuken : Notice Regarding the Status of Own Share Repurchase
December 30, 2023 at 11:51 pm EST
Share
December 1, 2023
Press Release SUZUKEN CO., LTD.
Shigeru Asano, President and CEO (Stock Code: 9987)
Securities Traded: Prime Markets of the Tokyo and Nagoya Stock Exchanges, and the Sapporo Securities Exchange
Contact: Yuichi Yamamoto, Executive Officer, Senior General Manager of Corporate Group Planning Headquarters
Tel.: +81-52-961-2331
Notice Regarding the Status of Own Share Repurchase
Suzuken Co., Ltd. hereby announces the result of November 2023 for the following items pertaining to the acquisition of treasury shares in accordance with the Articles of Incorporation pursuant to the provisions of Article 459, Paragraph 1 of the Companies Act.
Acquisition Details
(1) Type of shares acquired
Common shares
(2) Total number of shares acquired
3,263,300 shares
(3) Acquisition value
¥ 15,929,556,500
(4) Acquisition period
November 13, 2023 to November 30, 2023
(5) Acquisition method
Market purchase including Tokyo Stock
Exchange Trading Network Off-Auction Own
Share Repurchase Trading System (ToSTNeT-
3)
(Reference)
1. Details of Resolution to Acquire Treasury Shares (Announced on November 10, 2023)
(1) Type of shares to be acquired
Common shares
(2) Total number of shares to be acquired
6,000,000 shares (upper limit)
(% to total number of shares outstanding
(excluding treasury shares): 7.24%)
(3) Total acquisition value of shares
¥25 billion (upper limit)
(4) Acquisition period
November 13, 2023 to March 8, 2024
(5) Acquisition method
Market purchase including Tokyo Stock
Exchange Trading Network Off-Auction Own
Share Repurchase Trading System (ToSTNeT-
3)
2. Total number of treasury shares acquired based on the above resolution (as of November 30, 2023)
(1) Total number of shares acquired
3,263,300 shares
(2) Total acquisition value of shares
¥ 15,929,556,500
This is an English translation of a statement written initially in Japanese and is provided for reference purposes only. The Japanese original shall prevail in the event of any discrepancy between this document and the original.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Suzuken Co. Ltd. published this content on 01 December 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 December 2023 04:49:37 UTC.
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
SUZUKEN CO., LTD. 
